A new study clams dementia cases will double by 2060. Here’s what experts believe could be driving the rise in dementia rates and what you can do to help prevent it.
U.S. dementia cases are projected to double by 2060, with a new study predicting a rise in the burden of the disease nationally.
The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National Institutes of Health (NIH) annually submit a budget estimate directly to the president, detailing the resources required to implement initiatives under the National Alzheimer's Project Act.
Aging is a social process as well as a biological one, and we have to figure out ways to cope with our greying and the greying of society and the speed of change.
Often data revises our viewpoint on healthy ageing like the new study showing that the number of adults in the US living with dementia could increase from approximately 514,000 in 2020 to approximately 1 million in 2060. This was more pronounced in Afro-American adults.
Jan. 22, 2025 — Researchers demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid later in life, potentially predisposing them to late-onset ...
In the second finding on dementia, which was published in Nature ... with more than 2,000 participants in five sites across the United States. Results are expected to be reported in July.
Discover the link between REM sleep and Alzheimer's disease. Learn how delayed REM sleep may indicate elevated protein levels associated with the disease.
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with Alzheimer disease administered Leqembi.
On the flip side, recent studies show that GLP-1 medications may decrease a person’s risk for cardiovascular disease and dementia. Now, a new study recently published in the journal Nature Medicine reports that taking GLP-1 medications may provide ...
Four out of five older adults who likely have dementia may be unaware of their condition, according to findings from a cohort study published in the Journal of General Internal Medicine.Researchers reported especially high lack of awareness among older Mexican Americans that could be the result of physicians withholding a diagnosis for numerous reasons.
Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite complexity of the human brain,